EVERSANA Acquires Protean
October 15, 2021
EVERSANA has acquired Protean, a market access consulting firm that specializes in channel and trade, patient services and payer contracting operations. The deal integrates Protean’s operational experts and proprietary tools into EVERSANA’s consulting and commercial services to expand market access, channel and patient services capabilities for life sciences clients.
- Buyers
- EVERSANA
- Targets
- Protean
- Industry
- Healthcare Services
- Location
- North Carolina, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
EVERSANA Acquires Alkemy Partners
September 9, 2020
Healthcare Services
EVERSANA, a Chicago-based provider of commercial services to the life science industry, has acquired Alkemy Partners, a New Hampshire–based field learning and development firm that provides training, content creation and digital solutions for market access, sales and clinical engagement. The deal expands EVERSANA's field solutions and training capabilities — adding medical writing, training facilitation, leadership development and multimedia/digital learning capabilities to its commercial services platform. Financial terms were not disclosed.
-
EVERSANA Acquires Accelera Canada and Partner Companies
July 26, 2021
Healthcare Services
EVERSANA acquired Toronto-based Accelera Canada and its partner companies Patient Access Solutions, Podium Strategic Partners, Inc., and Advocacy Solutions to expand its commercial services footprint in Canada. The deal adds market access, patient advocacy and patient-support capabilities to EVERSANA's global life sciences commercialization platform and brings several Accelera founding partners and staff into EVERSANA's Canadian team.
-
EVERSANA Acquires Intouch Group
December 21, 2021
Marketing & Advertising
EVERSANA has completed its acquisition of Intouch Group, a global full-service agency network serving the pharmaceutical industry. The deal integrates Intouch’s creative, media, enterprise solutions and data analytics into EVERSANA’s commercialization services platform to expand capabilities and accelerate digital-first commercialization for life sciences clients.
-
EVERSANA Acquires HVH Precision Analytics
July 15, 2020
Data & Analytics
EVERSANA has acquired HVH Precision Analytics and its predictive AI/ML analytics platform from prior owners Havas Health & You and Perspecta. The acquisition brings a military-grade predictive analytics capability into EVERSANA's integrated commercial services for life sciences, while an exclusive strategic partnership will maintain client continuity with Havas Health & You; financial terms were not disclosed.
-
EVERSANA Merges with Waltz Health
August 26, 2025
Healthcare Services
EVERSANA announced a merger with Waltz Health to combine EVERSANA’s end-to-end pharmaceutical commercialization services with Waltz’s AI-driven prescription routing and payer-facing marketplace technology. Mark Thierer, co-founder and CEO of Waltz Health, will serve as CEO of the combined organization as the companies integrate capabilities to improve drug affordability, payer connectivity and patient access for specialty and high-cost therapies.
-
Trinity Acquires EVERSANA's APACME Advisory Services
November 5, 2025
Healthcare Services
Trinity Life Sciences has acquired EVERSANA’s advisory services operation across Asia-Pacific and the Middle East (APACME), bringing regional teams in Singapore, Tokyo, Mumbai, Shanghai, Sydney and Dubai into Trinity’s global footprint. The transaction deepens Trinity’s local life‑sciences commercialization capabilities while EVERSANA will continue to operate its broader commercialization services and maintain a strategic collaboration with Trinity for shared clients.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.